Sayed Z, Hieba E, Batakoushy H, Rashdan H, Ismail E, Elkatlawy S
RSC Adv. 2024; 14(53):39297-39324.
PMID: 39670162
PMC: 11635600.
DOI: 10.1039/d4ra06992g.
Kalantari H, Turner R
Front Chem. 2024; 12:1482102.
PMID: 39605957
PMC: 11598438.
DOI: 10.3389/fchem.2024.1482102.
El-Seedi H, Omara M, Omar A, Elakshar M, Shoukhba Y, Duman H
Bioengineering (Basel). 2024; 11(11).
PMID: 39593755
PMC: 11591867.
DOI: 10.3390/bioengineering11111095.
Jeong Y, Park J, Khang D
Int J Nanomedicine. 2024; 19:11767-11788.
PMID: 39553460
PMC: 11566213.
DOI: 10.2147/IJN.S496028.
Dhiman A, Rana D, Benival D, Garkhal K
Ther Deliv. 2024; 16(1):87-115.
PMID: 39445563
PMC: 11703381.
DOI: 10.1080/20415990.2024.2415281.
Decarbonizing progress: Exploring the nexus of renewable energy, digital economy, and economic development in South American countries.
Li W, Nadeem M
Heliyon. 2024; 10(13):e33446.
PMID: 39071722
PMC: 11283105.
DOI: 10.1016/j.heliyon.2024.e33446.
Stimuli-Responsive Liposomes of 5-Fluorouracil: Progressive Steps for Safe and Effective Treatment of Colorectal Cancer.
Alrbyawi H
Pharmaceutics. 2024; 16(7).
PMID: 39065663
PMC: 11280302.
DOI: 10.3390/pharmaceutics16070966.
An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success.
Kumbhar P, Kumar P, Lasure A, Velayutham R, Mandal D
Discov Nano. 2023; 18(1):156.
PMID: 38112935
PMC: 10730792.
DOI: 10.1186/s11671-023-03913-6.
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.
Hasan N, Nadaf A, Imran M, Jiba U, Sheikh A, Almalki W
Mol Cancer. 2023; 22(1):168.
PMID: 37803407
PMC: 10559482.
DOI: 10.1186/s12943-023-01854-3.
Nanoparticles in Medicine: Current Status in Cancer Treatment.
Pavelic K, Kraljevic Pavelic S, Bulog A, Agaj A, Rojnic B, colic M
Int J Mol Sci. 2023; 24(16).
PMID: 37629007
PMC: 10454499.
DOI: 10.3390/ijms241612827.
Copolymer-Green-Synthesized Copper Oxide Nanoparticles Enhance Folate-Targeting in Cervical Cancer Cells In Vitro.
Jagaran K, Singh M
Polymers (Basel). 2023; 15(10).
PMID: 37242968
PMC: 10223539.
DOI: 10.3390/polym15102393.
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities.
Kashyap B, Singh V, Solanki M, Kumar A, Ruokolainen J, Kesari K
ACS Omega. 2023; 8(16):14290-14320.
PMID: 37125102
PMC: 10134471.
DOI: 10.1021/acsomega.2c07840.
Biosynthesis of Gold and Silver Nanoparticles Using Phytochemical Compounds.
Zuhrotun A, Oktaviani D, Hasanah A
Molecules. 2023; 28(7).
PMID: 37050004
PMC: 10096681.
DOI: 10.3390/molecules28073240.
Drug Release from Nanoparticles (Polymeric Nanocapsules and Liposomes) Mimed through a Multifractal Tunnelling-Type Effect.
Bacaita E, Rata D, Cadinoiu A, Ghizdovat V, Agop M, Luca A
Polymers (Basel). 2023; 15(4).
PMID: 36850302
PMC: 9962169.
DOI: 10.3390/polym15041018.
Dendrimers as Modifiers of Inorganic Nanoparticles for Therapeutic Delivery in Cancer.
Zenze M, Daniels A, Singh M
Pharmaceutics. 2023; 15(2).
PMID: 36839720
PMC: 9961584.
DOI: 10.3390/pharmaceutics15020398.
Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target.
Yarahmadi A, Sohan R, McAllister B, Caromile L
Mol Cell Oncol. 2022; 9(1):2136476.
PMID: 36313480
PMC: 9601542.
DOI: 10.1080/23723556.2022.2136476.
AuNP/Chitosan Nanocomposites Synthesized through Plasma Induced Liquid Chemistry and Their Applications in Photothermal Induced Bacteria Eradication.
Guo Z, Sun D, Zhou X, Xu H, Huang Y, Chu C
Pharmaceutics. 2022; 14(10).
PMID: 36297582
PMC: 9611015.
DOI: 10.3390/pharmaceutics14102147.
Novel archetype in cancer therapeutics: exploring prospective of phytonanocarriers.
Yadav N, Singh D, Rawat M, Sangwan N
3 Biotech. 2022; 12(11):324.
PMID: 36276448
PMC: 9569404.
DOI: 10.1007/s13205-022-03372-3.
Aptamer-Based Cancer Cell Analysis and Treatment.
Wu L, Zhang Y, Wang Z, Zhang Y, Zou J, Qiu L
ChemistryOpen. 2022; 11(10):e202200141.
PMID: 36264016
PMC: 9583543.
DOI: 10.1002/open.202200141.
Induction of ROS mediated genomic instability, apoptosis and G0/G1 cell cycle arrest by erbium oxide nanoparticles in human hepatic Hep-G2 cancer cells.
Safwat G, Soliman E, Mohamed H
Sci Rep. 2022; 12(1):16333.
PMID: 36175500
PMC: 9522848.
DOI: 10.1038/s41598-022-20830-3.